Life-long Tele-monitoring of Patients With Type 2 Diabetes Mellitus in Central Greece

NCT ID: NCT01498367

Last Updated: 2015-02-18

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

154 participants

Study Classification

INTERVENTIONAL

Study Start Date

2011-03-31

Study Completion Date

2014-01-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To evaluate whether patients with type 2 diabetes mellitus can be followed by simplified, centralized and large scale tele-monitoring of blood glucose levels and blood pressure, and whether this intervention produces health and economic benefits when introduced without major changes to the existing organization of a large tertiary care center.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The present study aims to examine the clinical and financial effects and the patients' perception and satisfaction of home telemedicine support system for diabetes management versus standard (usual) care. In the intervention group the patients will be provided with a blood glucose meter and a mobile phone and their data will be transferred via the mobile to the regional database and will be assessed by the allocated care team. Appropriate counseling on treatment and symptoms or problems related to diabetes will also be provided.

Measurements of HbA1c will be taken to assess glycaemic control while the dietary and the exercise habits will be assessed by the use of questionnaires. In addition the patients' satisfaction from the use of the telemedicine service will be studied. A Cost-Effective Analysis and Cost Utility Analysis will be applied to evaluate the tele-health service compared with the usual care from the health and social perspective. The effect of the tele-health service in the organization structure of the outpatient hospital department will be evaluated with a qualitative study.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Diabetes Mellitus, Type 2

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

SUPPORTIVE_CARE

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Usual care

Participants in the control group receive usual care. Usual care consists of regular visits to the specialist when required. In the occasion of the visit, HbA1c and glucose measurements are performed and the current oral or insulin therapy is modified if necessary. Patients also receive basic education in the management of diabetes.

Group Type NO_INTERVENTION

No interventions assigned to this group

Telemonitoring of diabetes 2 patients

Patients will have one educational visit to set up the system and explain how it works. Patients will download their measurements from their tele-glucose meter to their mobile phone and the data will be transferred to the regional database. The care team (a nurse specially trained and the allocated physician) will regularly access the patient's home diary, and will provide the appropriate counselling and medication changes as frequently as necessary. In addition to blood glucose measurements, routine questions about symptoms and eventual difficulties related to diabetes as well as diabetic management will be routinely captured and reported.

Group Type EXPERIMENTAL

Telemonitoring of patients with diabetes type 2

Intervention Type PROCEDURE

Telemonitoring of the patients's blood glucose level measurements using a the tele-glucose meter

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Telemonitoring of patients with diabetes type 2

Telemonitoring of the patients's blood glucose level measurements using a the tele-glucose meter

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Diagnosis of type 2 Diabetes
* HbA1c \> 53 mmol/mol (7.0 % according to NGSP)
* Capability to use the devices provided
* Being cognitively able to participate
* Capability of filling in questionnaires in german or greek language
* Absence of severe comorbidity prevalent on diabetes with life expectancy \< 12 months

Exclusion Criteria

* Pregnancy
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Ministry for Health and Social Solidarity, Greece

OTHER

Sponsor Role collaborator

Municipality of Trikala, Greece

OTHER

Sponsor Role collaborator

e-Trikala S.A.

INDUSTRY

Sponsor Role collaborator

Cities Net SA

INDUSTRY

Sponsor Role collaborator

Institute of Biomedical Research & Technology, Larissa, Greece

OTHER

Sponsor Role collaborator

Institute of Communications and Computer Systems, Athens, Greece

OTHER

Sponsor Role collaborator

Alexander Technological Educational Institute, Thessaloniki, Greece

OTHER

Sponsor Role collaborator

University of Macedonia, Thessaloniki, Greece

OTHER

Sponsor Role collaborator

University of Thessaly

OTHER

Sponsor Role collaborator

Regional Health Authority of Sterea & Thessaly

OTHER_GOV

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Georgios Koukoulis

Associate Proffesor, Director of the Endocrinology and Metabolic Diseases Department, University Hospital of Larissa

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Georgios Koukoulis, MD, PhD

Role: PRINCIPAL_INVESTIGATOR

Endocrinology and Metabolic Diseases Department - Regional University Hospital of Larisa

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Endocrinology and Metabolic Diseases Department - Regional University Hospital of Larisa

Larissa, Thessaly, Greece

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Greece

References

Explore related publications, articles, or registry entries linked to this study.

Polisena J, Tran K, Cimon K, Hutton B, McGill S, Palmer K. Home telehealth for diabetes management: a systematic review and meta-analysis. Diabetes Obes Metab. 2009 Oct;11(10):913-30. doi: 10.1111/j.1463-1326.2009.01057.x. Epub 2009 Jun 16.

Reference Type BACKGROUND
PMID: 19531058 (View on PubMed)

Klonoff DC. Diabetes and telemedicine: is the technology sound, effective, cost-effective, and practical? Diabetes Care. 2003 May;26(5):1626-8. doi: 10.2337/diacare.26.5.1626. No abstract available.

Reference Type BACKGROUND
PMID: 12716831 (View on PubMed)

Jaana M, Pare G. Home telemonitoring of patients with diabetes: a systematic assessment of observed effects. J Eval Clin Pract. 2007 Apr;13(2):242-53. doi: 10.1111/j.1365-2753.2006.00686.x.

Reference Type BACKGROUND
PMID: 17378871 (View on PubMed)

Related Links

Access external resources that provide additional context or updates about the study.

http://www.renewinghealth.eu/

"The Renewing Health project is partially funded under the ICT Policy Support Programme (ICT PSP) as part of the Competitiveness and Innovation Framework Programme by the European Community"

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EC Grant Agreement 250487

Identifier Type: OTHER_GRANT

Identifier Source: secondary_id

FR2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Telehealth Approach to Enhancing Glycemic Control
NCT06830135 NOT_YET_RECRUITING NA